Meibopatch Heatable Eye Mask x1 Pack

Product Information

We searched for randomized clinical trials (RCTs) in Embase, MEDLINE, the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Web of Science, and ClinicalTrials.gov up to 4 January 2021. The subjective symptoms, objective tests of dry eye, meibomian gland function, and the incidence of adverse events were evaluated. Results Finis D, Hayajneh J, König C, Borrelli M, Schrader S, Geerling G (2014) Evaluation of an automated thermodynamic treatment (LipiFlow ®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial. Ocul Surf 12:146–154. https://doi.org/10.1016/j.jtos.2013.12.001

Naviblef ® Intensive Care is a foam formulation containing Tea Tree Oil intended for hygiene and the mechanical removal of severe ocular secretions and debris from eyelashes and eyelids. Naviblef ® Daily Care is recommended to be used as daily maintenance care for patients that have followed blepharitis treatment with Naviblef ® Intensive Care. 2Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, Lemp MA, Sullivan DA (2011) The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci 52:1922–1929. https://doi.org/10.1167/iovs.10-6997a Safety is of paramount importance to the pharmaceutical industry. VISUfarma makes every effort to provide helpful, accurate information which is compliant with industry regulations. The Meibopatch is a microwaveable eye mask for the treatment for Meibomian Gland Dysfunction (MGD), blepharitis, chalazions, crusting, cysts and dry eye syndrome. Korb DR, Greiner JV, Herman J (2001) Comparison of fluorescein break-up time measurement reproducibility using standard fluorescein strips versus the Dry Eye Test (DET) method. Cornea 20:811–815. https://doi.org/10.1097/00003226-200111000-00007 Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O’Brien T, Rolando M, Tsubota K, Nichols KK (2011) The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 52:2050–2064. https://doi.org/10.1167/iovs.10-6997g

The definition and classification of dry eye disease (2007) report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 5:75–92. https://doi.org/10.1016/s1542-0124(12)70081-2 Naviblef ® Intensive Care may be used to remove severe secretions from the eyelids and eyelashes caused by the following conditions: Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, Viso E, Vitale S, Jones L (2017) TFOS DEWS II epidemiology report. Ocul Surf 15:334–365. https://doi.org/10.1016/j.jtos.2017.05.003 Pult H, Riede-Pult BH, Purslow C (2012) A comparison of an eyelid-warming device to traditional compress therapy. Optom Vis Sci 89:E1035-1041. https://doi.org/10.1097/OPX.0b013e31825c3479Naviblef ® Daily Care may be used regularly to remove secretions from the eyelids and eyelashes caused by the following conditions: Naviblef ® Daily Care is a foam formulation containing Tea Tree Oil for the effective removal of excessive oil, pollen, ocular secretions or other debris from the eyelids that may lead to eye irritation, including blepharitis caused by Demodex and bacterial infestations or dry eye symptoms. 2